Search

everythinglearnresearchcommunity

for

Search:↓

Deleting Gpr54 speeds up hair growth and regeneration.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Adenosine led to higher patient satisfaction than minoxidil for hair loss treatment.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

A girl with type 1 diabetes developed a serious eye condition very early, suggesting the need for earlier eye checks and that early treatment can work well.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Skin symptoms can indicate endocrine disorders and have various treatments.

Higher leptin levels link to hair loss.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Platelet-rich plasma is considered safe but needs more research to prove its effectiveness in medical treatments.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Alginate is great for tissue engineering because it's safe, easy to use, and helps heal tissues.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Hair loss causes stress and affects mental health; treatment and support needed.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

New therapies show promise for wound healing, but more research is needed for safe, affordable options.

Patients with acne vulgaris have lower serum irisin levels.